Brief: Cvrx Announces Initiation Of Benefit-Hf, A Landmark Heart Failure Trial
22/01/2026 23:10
Jan 22 (Reuters) - CVRx Inc CVRX.O: CVRX ANNOUNCES INITIATION OF BENEFIT-HF, A LANDMARK HEART FAILURE TRIAL EVALUATING BAROSTIM IN SIGNIFICANTLY EXPANDED POPULATION CVRX INC - PRIMARY ENDPOINT: ALL-CAUSE MORTALITY AND HEART FAILURE DECOMPENSATION EVENTS CVRX INC - ENROLLMENT IS EXPECTED TO BEGIN IN THE FIRST HALF OF 2026 Source text: ID:nGNX8GlVcG Further company coverage: CVRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cvrx
See all newsBrief: Cvrx Appoints John Landry As Chief Financial Officer
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
CVRx, Inc. reports results for the quarter ended June 30 - Earnings Summary
CVRx Q2 revenue beats estimates, outlook cut on sales force, payer challenges
Brief: CVRx Q2 Revenue USD 15.705 Million Vs. IBES Estimate USD 15.5 Million